Chronic Disease
-
Chronic Disease | Neurological
Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
The Proclaim XR SCS provides an alternative to traditional treatment approaches like oral medication.Sam Brusco, Associate Editor 01.26.23
-
Chronic Disease
Tandem Diabetes Completes Deal for AMF Medical
AMF Medical is the Swiss developer of the Sigi patch pump.Sam Brusco, Associate Editor 01.23.23
-
Chronic Disease
Helio Genomics Evaluates New Approach to Colon Cancer Detection
Study confirms that MESAs combined approach is superior at distinguishing between colon cancer patients and healthy individuals compared to other methods.Charles Sternberg, Associate Editor 01.19.23
-
Chronic Disease | Diagnostics
Burning Rock's Multi-Cancer Blood Test Gains Breakthrough Status
OverC MCDBT aims to detect multiple cancer types (esophageal, liver, lung, ovarian, and pancreatic).Sam Brusco, Associate Editor 01.04.23
-
Chronic Disease | Digital Health
FDA OKs MedCognetics' QMTriage AI-Enabled Breast Cancer Screening Software
Company’s AI tech used to improve medical imaging efficiency and effectiveness to help radiologists with unmanageable caseloads.Sam Brusco, Associate Editor 12.14.22
-
Chronic Disease
Researchers Develop Hand-Held Biosensor for Detection of Oral Cancer
The group's biosensor consists of a sensor strip, similar to a glucose strip, and a circuit board for detection.Charles Sternberg, Associate Editor 12.13.22
-
Chronic Disease
Eli Lilly Ends Insulin Pump Partnership with Ypsomed
Lilly wants to focus on drug portfolio; Ypsomed will continue development as planned and seek a new commercial partner.Sam Brusco, Associate Editor 12.13.22
-
Chronic Disease
Tandem Diabetes to Buy Sigi Insulin Pump Maker AMF Medical
The deal for the Swiss insulin patch pump maker is valued at up to CHF 192 million ($205.2 million).Sam Brusco, Associate Editor 12.13.22
-
Chronic Disease
Researchers Develop New Method for Multi-Cancer Early Detection
A new, previously untested method based on human metabolism can easily find multiple types of newly formed cancers at the same time.Charles Sternberg, Associate Editor 12.12.22
-
Chronic Disease | Digital Health
FDA OKs BIOCORP's Mallya Smart Insulin Pen Device
The smart sensor attaches to insulin pens injectors to make them connected devices.Sam Brusco, Associate Editor 12.08.22
-
Chronic Disease | Diagnostics
FDA Clears Avenda Health's AI-Powered Prostate Cancer Care Platform
Leverages patient-specific diagnostic information and deep-learning algorithms to generate a tailored map of locations of cancer in the prostate.Sam Brusco, Associate Editor 12.08.22
-
Chronic Disease | Patient Monitoring
Dexcom G7 Continuous Glucose Monitor Earns FDA Nod
Cleared in the U.S. for people with all types of diabetes ages two years and older.Sam Brusco, Associate Editor 12.08.22
-
Chronic Disease
FDA OKs Electromed's Fifth-Gen HFCWO Airway Clearance Generator
SmartVest Clearway airway clearance system delivers high-frequency chest wall oscillation (HFCWO) therapy.Sam Brusco, Associate Editor 11.30.22
-
Chronic Disease
A Long Way to Go: How AI Powered Tech Can Close the Gap on Long COVID
Advanced precision imaging validated and enabled by AI technology can be a vital tool in the effort to clinically understand long COVID.Online Exclusives Dr. Rajarshi Banerjee, CEO of Perspectum 11.22.22
-
Chronic Disease
Sweetch Welcomes Dr. Fatima Cody Stanford as an Advisor
Stanford will help Sweetch implement obesity management practices with her far-reaching expertise in obesity care models.Charles Sternberg, Associate Editor 11.22.22
-
Chronic Disease
Varian Manufactures First Halycon Radiotherapy System at Kemnath Site
Following its acquisition of Varian, Siemens Healthineers installed a new production line and created 50 new jobs.Charles Sternberg, Associate Editor 11.21.22
-
Chronic Disease
Healiva Acquires B. Braun's Cell Therapy Manufacturing Assets
Acquisition will accelerate the launch of Healiva’s personalized skin regeneration therapy, EpiDex.Sam Brusco, Associate Editor 11.21.22
-
Chronic Disease
Medtronic Launches Extended Infusion Set in U.S.
The first and only infusion set for insulin pumps labelled for up to 7-day wear.Charles Sternberg, Associate Editor 11.16.22
-
Chronic Disease
Tandem Diabetes Care Shares Positive Results from Study Evaluating Control-IQ Technology
The data demonstrates that Control-IQ technology is safe and can offer considerable benefits to individuals with type 2 diabetes.Charles Sternberg, Associate Editor 11.15.22
-
Chronic Disease | Neurological
NeuroMetrix Strategically Launches Quell Fibromyalgia Device
First medical device authorized by FDA to reduce fibromyalgia symptoms.Sam Brusco, Associate Editor 11.07.22
